retatrutide clinical trials update 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide Before and After: Doctor

Glucagon receptor activation is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis) though these effects remain under investigation in humans and should not be taken as established clinical outcomes

Among available agents, dulaglutide (Trulicity) was highlighted for its relatively high brain penetrationreported at approximately 62%and its ability in experimental models to influence oxidative stress, amyloid handling, and neuronal energy metabolism [22]

Allergic Reactions: From mild skin reactions to severe anaphylaxis, allergic responses to Ozempic have been noted, requiring immediate medical attention in severe cases

The breakthrough came from the Gila monster

Designed with neurologists and data scientists, this graphic-heavy app makes it easy to record and monitor migraine attacks